.

BioPharmaceutical Business Intelligence

  • Uncover prior art in expired and abandoned patents
  • Obtain formulation and manufacturing information
  • Drug patents in 130+ countries

Serving leading biopharmaceutical companies globally:

AstraZeneca
Johnson and Johnson
Moodys
Cipla
Teva
Covington
McKinsey
Argus Health
McKesson
Medtronic

Pharmaceutical companies with the most orphan drugs

Orphan drug exclusivity is granted to drugs addressing rare 'orphan diseases' — those affecting fewer than 200,000 Americans.

The protection granted to orphan drugs is quite strong. The FDA is barred from approving any other biologic or small-molecule drug, generic/follow-on or otherwise, treating the same orphan disease for seven years.

This chart shows the companies which have received the most orphan drug exclusivities in the past five years.

The companies with the most orphan drug approvals are:

Back to Pharmaceutical Industry Infographics

For more information try a trial or see the plans and pricing

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:

botpot